Combination of Quinupristin-Dalfopristin (Synercid) and Rifampin Is Highly Synergistic in Experimental Staphylococcus aureus Joint Prosthesis Infection

We compared the efficacies of quinupristin-dalfopristin (Q-D; 30 mg/kg of body weight every 8 h) and vancomycin (60 mg/kg twice daily), alone or in combination with rifampin (10 mg/kg twice daily), in a rabbit model of methicillin-resistant Staphylococcus aureus knee prosthesis infection. In contras...

Ful tanımlama

Detaylı Bibliyografya

Yayımlandı:	Antimicrob Agents Chemother
Asıl Yazarlar:	Saleh-Mghir, Azzam, Ameur, Nourdine, Muller-Serieys, Claudette, Ismael, Farid, Lemaitre, Françoise, Massias, Laurent, Feger, Céline, Bléton, Rémy, Crémieux, Anne-Claude
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	American Society for Microbiology (ASM) 2002
Konular:	Experimental Therapeutics
Online Erişim:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC127098/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11897604/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.4.1122-1124.2002
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!